Catalent, Inc (CTLT) Covered Calls

Catalent Inc is a provider of delivery technologies and development solutions for drugs, biologics and consumer health products. Its segments include Oral Technologies, Medication Delivery Solutions and Development & Clinical Services.

You can sell covered calls on Catalent, Inc to lower risk and earn monthly income. Born To Sell's covered call screener gives you customized search capabilities across all possible covered calls but here are a couple of examples for CTLT (prices last updated Fri 12:15 PM ET):

Catalent, Inc (CTLT) Stock Quote
Last Change Bid Ask Volume P/E Market Cap
54.50 +0.21 54.48 54.52 136K 51 7.9B
Covered Calls For Catalent, Inc (CTLT)
Expiration Strike Call Bid Net Debit Return
If Flat
Return If Flat
Aug 16 55 1.55 52.97 2.9% 36.5%
Oct 18 55 3.50 51.02 6.9% 27.4%
Subscribers get access to the full covered call chain, and more features.

Want to make money with covered calls?  Sign Up For A Free Trial

Extended Business Description

Catalent, Inc. provides delivery technologies and development solutions. The company operates through three segments include: Oral Technologies, Medication Delivery Solutions and Development & Clinical Services. The Oral Technologies segment includes the Softgel Technologies and Modified Release Technologies businesses; this segment provides formulation, development and manufacturing of prescription and consumer health products using proprietary softgel, liqui-gels, vegicaps, optishell, optidose, optimelt, and zydis technologies; as well as other proprietary and conventional oral drug delivery technologies. The Medication Delivery Solutions segment engages in formulation, development, and manufacturing for prefilled syringes and other injectable formats; blow-fill-seal unit dose development and manufacturing; and biologic cell line development and manufacturing, including GPEx and SMARTag technologies. The Development & Clinical Services segment engages in manufacturing, packaging, storage, distribution and inventory management for global clinical trials of drugs and biologics; analytical and bioanalytical development and testing; scientific and regulatory consulting services; development services and manufacturing for conventional oral dose forms; and development and manufacturing of products. Catalent, Inc. was founded in April 2007 and is headquartered in Somerset, NJ.